SCHEMBL3068974

SCHEMBL3068974

C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3[C@@H]4CC[C@@H]4[C@@](O)(CCC4OCCO4)[C@@]3(C)CC[C@@H]12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 8/20 0.55
NR3C1 P04150 5/20 0.55
PGR P06401 4/20 0.55
ALDH1A1 P00352 3/20 0.55
ADRA1A P35348 1/20 0.55
HTR2B P41595 1/20 0.55
LMNA P02545 8/20 0.52
SERPINA6 P08185 7/20 0.52
HSD17B10 Q99714 7/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
TSHR P16473 5/20 0.52
BLM P54132 4/20 0.52
CYP2C19 P33261 3/20 0.52
CYP3A4 P08684 3/20 0.52
PMP22 Q01453 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HIF1A Q16665 2/20 0.52
MAPT P10636 2/20 0.52
ADORA3 P0DMS8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3068078 0.96 SHBG (0.53) SHBGNR3C1PGRALDH1A1ADRA1A
SCHEMBL3057144 0.85 SHBG (0.58) SHBGNR3C1PGRALDH1A1ADRA1A
SCHEMBL14713210 0.85 SHBG (0.58) SHBGNR3C1PGRALDH1A1ADRA1A
SCHEMBL11508378 0.85 SHBG (0.58) SHBGNR3C1PGRALDH1A1ADRA1A
SCHEMBL3246003 0.84 SHBG (0.57) SHBGNR3C1PGRALDH1A1ADRA1A
SCHEMBL3073418 0.83 SHBG (0.55) SHBGNR3C1PGRALDH1A1ADRA1A
Potassium Ion SCHEMBL10786275 0.83 SHBG (0.55) SHBGNR3C1PGRALDH1A1ADRA1A
SCHEMBL10783197 0.83 NR3C1 (0.55) SHBGNR3C1PGRALDH1A1ADRA1A
SCHEMBL7793950 0.82 SHBG (0.54) SHBGNR3C1PGRALDH1A1ADRA1A
SCHEMBL10959339 0.80 PSEN1 (0.58) SHBGNR3C1PGRALDH1A1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383809-B2 Process for the preparation of drospirenone NEWCHEM S.P.A. (IT) 2013-02-26 US disclosed
EP-2019114-B1 Process for the preparation of Drospirenone NEWCHEM S P A (IT) 2010-12-15 EP disclosed
US-20100222571-A1 PROCESS FOR THE PREPARATION OF DROSPIRENONE NEWCHEM S.P.A. (IT) 2010-09-02 US disclosed
EP-2019114-A1 Process for the preparation of Drospirenone Newchem S.p.A. (IT) 2009-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222571-A1 PROCESS FOR THE PREPARATION OF DROSPIRENONE CYP17A1, CYP19A1, DHCR7 SHBG 173/4885NR3C1 311/4885PGR 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.